Safety assessment of coenzyme Q10 (CoQ10)

BioFactors

Volumn 32, Issue 1-4, 2008, Pages 199-208

  Hidaka, Takayoshi ^a   Fujii, Kenji ^a   Funahashi, Iwao ^a   Fukutomi, Naoki ^a   Hosoe, Kazunori ^a  

^a KANEKA CORPORATION   (Japan)

Author keywords

ADI; Coenzyme Q10; CoQ10; CoQ10 biosynthesis; Dietary supplement; OSL; Safety profile; Ubiquinol

Indexed keywords

ALPHA TOCOPHEROL; KANEKA QH; PLACEBO; PURESORB Q; UBIDECARENONE; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; BIOSYNTHESIS; CHRONIC TOXICITY; CONFERENCE PAPER; DIET SUPPLEMENTATION; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG DOSE ESCALATION; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FECES; GENOTOXICITY; HEADACHE; HEARTBURN; HUMAN; INVOLUNTARY MOVEMENT; IRRITABILITY; MAXIMUM TOLERATED DOSE; NAUSEA; NONHUMAN; PLASMA; PRIORITY JOURNAL; RASH; REPEATED DRUG DOSE; REPRODUCTIVE TOXICITY; RISK ASSESSMENT; SIDE EFFECT; SINGLE DRUG DOSE; SKIN PRURITUS; STOMACH DISCOMFORT; TOXICITY TESTING;

ANIMALIA; RATTUS;

EID: 58149389379     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520320124     Document Type: Conference Paper

References (54)

1. F. Åberg, E.-L. Appelkvist, G. Dallner and L. Ernster, Distribution and redox state of ubiquinones in rat and human tissues, Arch Biochem Biophys 295 (1992), 230-234.
2. 10 as adjuvant therapy in heart failure, Molecular Aspects of Medicine (Suplement) 15 (1994), s287-s294.
3. D. Benford, The acceptable daily intake: A tool for ensuring food safety, ILSI Europe Concise Monograph Series (2000), 1-38.
4. 10 formulations, Mitochondrion 7S (2007), S78-S88.
5. T. Chiba, T. Watanabe, Y. Kume, K. Sugiyama and H. Shiojiri, Toxicological studies of ubiquinone-10 (I) Acute toxicity test in rats and mice and subacute and chronic toxicity tests in rats, Ouyou Yakuri 6(4) (1972), 769-779, (Abstract in English).
6. T. Chiba, K. Sugiyama, Y. Kume, H. Shiojiri, T. Watanabe and M. Ozeki, Toxicological studies of ubiquinone-10 (II) Subacute toxicity test in rabbits, Ouyou Yakuri 6(4) (1972), 781-786, (Abstract in English).
7. 10 formulations in human subjects, Internat J Vit Nutr Res 68 (1998), 109-113.
8. 10, J Am Coll Nutr 20(6) (2001), 591-598.
9. L. Ernster, and G. Dallner, Biochemical, physiological and medical aspects of ubiquinone function, Biochim Biophys Acta 1271 (1995), 195-204.
10. 10 tolerability in Huntington's disease, Movement Disorders 11(3) (1996), 321-323.
11. 10 in ALS, Neurology 65 (2005), 1834-1836.
12. 10 and its (2Z)-isomer in rats; single and four-week repeated dose toxicity studies, J Nutr Sci Vitamol 52 (2006), 9-20.
13. 10 (Ubiquinone), Regul Toxicol Pharmacol 45 (2006), 282-288.
14. J.N. Hathcock, Vitamin and Mineral Safety, (2nd ed.), Council for Responsible Nutrition, Washington DC, 2004, 1-44.
15. P.W. Luker, N. Wetzelsberger, G. Hennings and D. Rehn, Pharmacokinetics of coenzyme ubidecarenone in healthy volunteers, in: Biomedical and Clinical Aspects of Coenzyme Q, (Vol. 4), K. Folkers and Y. Yamamura, eds, Elsevier Science, Amsterdam, 1984, pp. 143-151.
16. 10 in rats, J Toxicol Sci 32(4) (2007), 437-448.
17. K. Hosoe, M. Kitano, H. Kishida, H. Kubo, K. Fujii and M. Kitahara, Study on safety and bioavailability of ubiquinol (Kaneka QHTM ) after single and 4-week multiple oral administration to heathy volunteers, Regul Toxicol Pharmacol 47 (2007), 19-28.
18. 10 and remacemide in Huntington's disease, Neurology 57 (2001), 397-404.
19. 10 (Kaneka Q10) in healthy subjects: A double-blind, randomized, placebo-control trial, Regul Toxicol Pharmacol 44 (2006), 212-218.
20. 10 in healthy human adults, Jpn J Food Chem 14(2) (2007), 76-81.
21. M. Kitano, D. Watanabe, S. Oda, H. Kubo, H. Kishida, K. Fujii, M. Kitahara and K. Hosoe, Subchronic oral toxicity of ubiquinol in rats and dogs, Int J Toxicol 27 (2008), 189-215.
22. M. Kitano, K. Hosoe, N. Fukutomi, T. Hidaka, R. Ohta, K. Yamakage and T. Hata, Evaluation of the mutagenic potential of ubidecarenone using three short-term assays, Food Chem Toxicol 44 (2006), 364-370.
23. M. Kitano, F. Mizuhashi, H. Kubo, H. Kishida, K. Fujii, M. Kitahara and K. Hosoe, Evaluation of the mutagenic and genotoxic potential of ubiquinol, Int J Toxicol 26(6) (2007), 533-544.
24. 10 in cardiovascular disease, BioFactors 9 (1999), 273-284.
25. 10, Int J Tiss Reac XII(3) (1990), 169-171.
26. M.V. Miles, The uptake and distribution of coenzyme Q(10), Mitochondrion 7S(2007), S72-S77.
27. 10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low density lipoprotein to the initiation of lipid peroxidation, Biochim Biophys Acta 1126 (1992), 247-254.
28. 10: Biliary and urinary excretion study in guinea pigs, BioFactors 9 (1999), 111-119.
29. 10 on development of fetuses and neonates in rats and mice, Iyakuhin Kenkyu 3(3) (1972), 306-315, (Abstract in English).
30. K. Nukui, T. Koike, T. Yamagishi, H. Ihota, T. Nagase, H. Kimura and K. Saito, A 91-d repeated dose oral toxicity study of PureSorb-Q™ 40 in rats, J Nutr Sci Vitaminol 53 (2007), 306-314.
31. 10 level in excessive dosing, J Nutr Sci Vitaminol 53 (2007), 198-206.
32. T. Okamoto, T. Matsuya, Y. Fukunaga, T. Kishi and T.Yamagami, Human serum ubiquinol-10 and relationship to serum lipids, Internat J Vit Nutr Res 59 (1989), 288-292.
33. 10 in health and disease, Eur J Clin Nutr 53 (1999), 764-770.
34. P.J. Quinn, J.P. Fabisiak and V.E. Kagan, Expansion of Antioxidant Function of Vitamin E by Coenzyme Q, BioFactors 9 (1999), 149-154.
35. A.G. Renwick, Safety factors and establishment of acceptable daily intakes, Food Additives and Contaminants 8(2) (1991), 135-150.
36. 10 in physical exercise, hypertension and heart failure, BioFactors 18 (2003), 91-100.
37. 10 in the treatment of hypertension: a meta-analysis of the clinical trials, J Hum Hypertens 21 (2007), 297-306.
38. 10 in Neurological Disorders, BioFactors 25 (2005), 117-126.
39. 10 in early Parkinson disease: evidence of slowing of the functional decline, Arch Neurol 59 (2002), 1541-1550.
40. 10 in patients with Parkinson's disease, Exp Neurol 188 (2004), 491-494.
41. R. Stocker and C. Suarna, Extracellular reduction of ubiquinone-1 and -10 by human Hep G2 and blood cells, Biochim Biophys Acta 1158 (1993), 15-22.
42. A. Storch, W.H. Jost, P. Viergge, J. Spiegel, W. Greulich, J. Durner, T. Muller, A. Kupsch, H. Henningssen, W.H. Oertel, G. Fuchs, W. Kuhn, P. Niklowitz, R. Koch, B. Herting and H, Reichmann; German Coenzyme Q(10) Study Group, Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease, Arch Neurol 64 (7) (2007), 938-944.
43. 10 preparation (Q10EP40) in rats, J Health Sci 51 (2005), 346-356.
44. S.R. Thomas and R. Stocker, Chapter 9: Mechanism of antioxidant action of ubiquinol-10 for low density lipoprotein, in: Coenzyme Q: Molecular Mechanisms in Health and Disease, V.E. Kagan and P.J. Quinn, eds, CRC Press, Boca Raton, 2001, pp. 131-150.
45. 10 in man, Internat J Clin Pharmacol Therap Toxicol 24 (1986), 536-541.
46. Toxicological principles for safety assessment of direct food additives and color additives in food (FDA, 1982).
47. M. Turunen, J. Olsson and G. Dallner, Metabolism and function of coenzyme Q, Biochim Biophys Acta 1660 (2004), 171-199.
48. 10 increases in rats when esterified forms are administered, J Nutr 129 (1999), 2113-2118.
49. Unpublished data (Kaneka Internal Report: Acute oral gavage lethality study with ubiquinone in rats, HWI6510-136, 1995).
50. K.D. Williams, J.D. Maneke, M. AbdelHameed, R.L. Hall, T.E. Palmer, M. Kitano and T. Hidaka, 52-week oral gavage chronic toxicity study with ubiquinone in rats with a 4-week recovery, J Agric Food Chem 47 (1999), 3756-3763.
51. S. Yamashita and Y. Yamamoto, Simultaneous detection of ubiquinol and ubiquinone in human plasma as marker of oxidative stress, Anal Biochem 250 (1997), 66-73.
52. Y. Zhang, F. Aberg, E.L. Appelkvist, G. Dallner and L. Ernster, Uptake of dietary coenzyme Q supplement is limited in rats, J Nutr 125 (1995), 446-453.
53. Y. Zhang, M. Turunen and E.L. Appelkvist, Restricted uptake of dietary coenzyme Q Is in contrast to the unrestricted uptake of α-tocopherol into rat organs and cells, J Nutr 126 (1996), 2089-2097.
54. 10: a report of 90-day repeated dose toxicity study in rats, J Toxicol Sci 32(5) (2007), 505-514.